Misconceptions about medications to treat chronic pain persist;patient education and proper adherence are critical to ensure that patients accrue maximum benefit from analgesics.

Certain events impact the patient?provider relationship and need to be monitored to ensure appropriate oversight of drug therapy.

Various treatment options are now available for patients with HIV. The 3 newest FDA approvals—maraviroc, raltegravir, and etravirine—are reviewed here.

Errors can occur at any step of the medication process—from prescribing to administration. Everyone involved in patient care must work to prevent these errors from occurring.